Fulgent BioPharma is here at #ASCO24! Let us know if you would like to meet to discuss our oncology biomarker services, including liquid biopsy molecular profiling, solid tumor profiling and more. Contact us for a meeting: http://tiny.cc/Fulgent #ASCO #Clinicaltrials #BioPharma #Oncology
Fulgent Genetics’ Post
More Relevant Posts
-
Join experts, Vladimir Bonevski and Kriti Jindal of IQVIA and Lien Lybaert of myNEO Therapeutics, on our latest webinar. Explore the evolving landscape of precision medicine and biomarker testing and its impact on oncology markets across different tumor types and geographies. Sign up: https://bit.ly/4cQjyjj #Oncology #PrecisionMedicine
To view or add a comment, sign in
-
-
Manta for oncology workflows 🧬 Running oncology workflows can be challenging. Working with tricky sample types and the constant struggle to meet those sky-high DNA/RNA quality standards. But, we’ve built Manta to tackle exactly these. ✅Flexible with sample load: Often oncology labs don’t get a heap of samples together. Manta can run just 1 or up to 32 samples in one go. ✅Enables various oncology applications: including diagnostics, BCR-ABL testing, and liquid biopsy research among others. ✅Optimal results: Manta delivers optimal results every time, no ifs, ands, or buts. If your lab works in the oncology sector and you’re looking to automate extraction workflows, let’s talk more: https://lnkd.in/guJ8VMND #oncology #molecularbiology #cancerdiagnostics #liquodbiopsy
To view or add a comment, sign in
-
In case you missed it… click here to view the AACR 2023 poster entitled “Inhibition of murine myeloid suppressor cells increases CD8 T cell activation in vitro” presented by Labcorp Discovery Research Associate Anita J. Zaitouna. With more than 6,000 discovery oncology studies completed, we have amassed extensive experience and deep insights to inform oncology research and enable quick, confident decisions about life-saving compounds. #CRO #discovery #oncology
To view or add a comment, sign in
-
Social media is a crucial tool in the quickly evolving field of oncology, where new findings, biomarkers, and treatments are introduced each month. #oncology #clinicaltrials #patientrecruitment #trialawareness #biomarkers #cancerresearch https://lnkd.in/gBb6iCWV
Hashtag Cancer: Social Media and Oncology
lighthouse.bio
To view or add a comment, sign in
-
Innovent is presenting clinical data on our first-in-class PD-1/IL-2α-bias bispecific antibody fusion protein (IBI363) at the 2024 ESMO Virtual Plenary, June 13-14. Read below about this antibody's promising safety signals, its broad anti-tumor activity and its applicability across tumor types. #ESMOVirtualPlenary #oncology #InnoventBiologics https://lnkd.in/guaqFQmN
To view or add a comment, sign in
-
-
Discover the transformative potential of antibody-drug conjugates (ADCs) in targeted cancer therapy. Our latest presentation dives deep into the journey of ADC development, from Paul Ehrlich's early concept of "magic bullets" to their current status as a leading treatment modality. Learn about the intricate bioanalytical challenges, cutting-edge techniques, and regulatory milestones shaping the future of ADCs in oncology. #CancerResearch #ADCs #Bioanalysis #PrecisionMedicine #WuXiAppTec https://hubs.li/Q02zVC290
Form
To view or add a comment, sign in
-
Our latest "Ask the Experts" features Dr. Robert Vries, CEO, diving deep into the exciting world of patient-derived organoids in cancer research! In this blog post, Dr. Vries explores: 💊The impact of the FDA Modernization Act 2.0 on organoid technology 🔬How organoids are revolutionizing oncology drug development 💊Our cutting-edge advancements in organoid services for drug discovery Discover how patient-derived organoids are paving the way for personalized cancer treatment. Read the full blog post here:https://bit.ly/4e445xA #cancerresearch #organoids #personalizedmedicine #drugdiscovery #innovation #tumororganoid #patientinthelab #oncology
To view or add a comment, sign in
-
Learn more about how to accelerate your #oncology #drugdiscovery, with Oncofactory's avian xenograft models for comprehensive early-phase assessment.
👉 Want to learn more about how to accelerate your oncology drug discovery with Oncofactory's embryo xenograft models? Let's revolutionize cancer research together! You and Oncofactory, contact us at: [email protected] #Innovation #lifescience #nonclinical #CRO #drugdevelopment #PDXmodel #partnering #oncology #testing #efficacy #research
To view or add a comment, sign in